What is the most common pathology for bladder cancer?

Urothelial carcinoma is the most common bladder cancer histology (~90%) diagnosed in the US, followed by squamous (2-5%), adenocarcinoma (2%), neuroendocrine (1%), and other rare tumors (<1%).

What is TCC in bladder cancer?

Urothelial carcinoma, also known as transitional cell carcinoma (TCC), is by far the most common type of bladder cancer. In fact, if you have bladder cancer it’s almost certain to be a urothelial carcinoma. These cancers start in the urothelial cells that line the inside of the bladder.

What cells cause bladder cancer?

Bladder cancer most often begins in the cells (urothelial cells) that line the inside of your bladder. Urothelial cells are also found in your kidneys and the tubes (ureters) that connect the kidneys to the bladder. Urothelial cancer can happen in the kidneys and ureters, too, but it’s much more common in the bladder.

What are 4 types of bladder cancer?

Knowing this helps your doctor decide which treatment you need. The most common type of bladder cancer is transitional cell bladder cancer. This is also called urothelial bladder cancer. Rarer types include squamous cell bladder cancer, adenocarcinoma, sarcoma and small cell bladder cancer.

How many stages does bladder cancer have?

There are 5 stages: stage 0 (zero) and stages I through IV (1 through 4). The stage provides a common way of describing the cancer, so doctors can work together to plan the best treatments. Staging can be clinical or pathological.

What is last stage of bladder cancer?

Stage 4 is the most advanced stage of cancer. At this stage, cancer cells will usually have spread beyond the original location of the disease to other organs. Doctors consider three key factors when determining the stage of bladder cancer: size and location of the original tumor.

What is the role of β-catenin in the pathogenesis of cancer?

Abnormal expression of β-catenin can cause many diseases, such as malignant tumors. In normal physiology, β-catenin can maintain the integrity of epithelial tissue and control the transcription of various extracellular genes. Abnormal expression of β-catenin can induce abnormal signaling pathway activity in normal cells.

What is the aberrant expression rate of β-catenin in bladder tissue?

Compared with normal bladder tissues, the aberrant expression rate of β-catenin in BC tissues was significantly increased (P<0.05), and the combined OR was 14.69 [5.73, 37.65] (Figure 2).

Is β-catenin expression higher in high-grade and non-muscle-invasive BC tissue?

Furthermore, the aberrant expression rates of β-catenin in high-grade and invasive BC tissues were notably higher than those in low-grade and non-muscle-invasive BC (NMIBC) tissues (P<0.05), and the combined ORs were 0.31 [0.23, 0.43] and 0.21 [0.15, 0.29] (Figures 3and ​and4).4).

Do reduced E-cadherin and a-catenin expressions have a role in bladder carcinoma?

Koksal I.T., Ates M. and Danisman A. (2006) Reduced E-cadherin and a-catenin expressions have no prognostic role in bladder carcinoma. Pathol. Oncol. Res.12, 13–19 10.1007/BF02893426 [PubMed] [CrossRef] [Google Scholar]